분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2017-08-14 16:03:20 , Hit : 819
 full.jpg (21.4 KB), Download : 7
 CRISPR Corrects RNA-based Disease Defects


Muscle cells from a patient with myotonic dystrophy type I, untreated (left) and treated with the RNA-targeting Cas9 system (right). The MBNL1 protein is in green, repetitive RNA in red, and the cell's nucleus in blue.

http://www.the-scientist.com/?articles.view/articleNo/50064/title/CRISPR-Corrects-RNA-based-Disease-Defects/&utm_campaign=NEWSLETTER_TS_The-Scientist-Daily_2016&utm_source=hs_email&utm_medium=email&utm_content=55196861&_hsenc=p2ANqtz-9_YDiUBs86US91j4DInDpaheYvIUjEpFbUfGlafwOelZqs1IEAalr9bCzm0xiDEheVQefwPrQY7FiTvQTLB_WfE43aRA&_hsmi=55196861


The Scientist »
The Nutshell


In human cells, researchers deploy the genome editor to snip out toxic repetitive sequences.

By Kerry Grens | August 10, 2017


UC SAN DIEGO HEALTH
Armed with a modified version of CRISPR-Cas9, scientists have removed nucleotide repeats from RNA in vitro that are known to cause diseases, namely, Huntington’s, ALS, and myotonic dystrophy. Cells from patients with myotonic dystrophy were restored to normal function after the CRISPR treatment, Gene Yeo of the University of California, San Diego, and colleagues report today (August 10) in Cell.

“It’s tempting to imagine how this exciting capability might be used to treat genetic diseases one day, although many additional studies are needed to test this possibility,” Harvard University professor David Liu, who was not part of the study, tells KPBS.

The study is an extension of previous work from Yeo’s lab developing the so-called RCas9 nuclease, which homes in on RNA rather than Cas9’s normal DNA target. The researchers used RCas9 to cut away microsatellite repeat extensions, strings of sequence copies responsible for disease.

See “RNA-Targeting CRISPR”

Lead author and postdoc Ranjan Batra points out the difference between targeting RNA and targeting DNA. “Any changes we make to DNA are permanent,” he tells KPBS. “Any changes that we make to RNA stay for only a few hours until a new RNA is made.”

Yeo tells the San Diego Union Tribune that a viral vector-administered RNA treatment could last 5-10 years. “The main thing we don’t know yet is whether or not the viral vectors that deliver RCas9 to cells would elicit an immune response,” he says in a statement. “Before this could be tested in humans, we would need to test it in animal models, determine potential toxicities and evaluate long-term exposure.”







1207   Outsourcing Gene Editing to the Public-Online Game Challenges Players to Design CRISPR On/Off Switch  이성욱 2017/09/05 795
1206   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 801
1205   Cancer Onset May Be Caused by Immune System Fighting Viruses  이성욱 2017/08/25 804
1204   Uncovering Functions of Circular RNAs  이성욱 2017/08/14 808
1203   [바이오토픽] 드디어 올 것이 왔다: CRISPR, 생존가능 인간배아의 질병초래 유전자 교정 성공  이성욱 2017/08/03 809
1202   Zika Update  이성욱 2016/03/15 814
  CRISPR Corrects RNA-based Disease Defects  이성욱 2017/08/14 819
1200   “유전자 치료 법률 금지 한국 유일” vs “생명체 설계도 바꾸는 건 문제”  이성욱 2017/08/28 821
1199   CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 833
1198   First In Vivo Human Genome Editing to Be Tested in New Clinical Trial  이성욱 2017/05/18 841
1197   Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 844
1196   유전자치료제 '인보사' 연골재생 입증못해도 허가받은 까닭  이성욱 2017/07/14 845
1195   [바이오토픽] FDA 자문위원회, CAR-T(chimeric antigen receptor T cell) 승인 만장일치로 권고  이성욱 2017/07/14 848
1194   First In Vivo Function Found for Animal Circular RNA  이성욱 2017/08/14 850
1193   ‘단세포 인공생명체’ 눈앞에 성큼  이성욱 2017/03/11 855
1192   Revisiting CAR T-Cells for Treating HIV Shows Promise  이성욱 2016/07/19 858
1191   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 861
1190   CRISPR Can Tag RNA  이성욱 2016/03/26 867
1189   유전자 가위로 바이러스 제거한 '청정 돼지' 나왔다  이성욱 2017/08/24 868
1188   독감바이러스의 ‘RNA 도둑질’  이성욱 2017/05/08 869

[1][2][3] 4 [5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2023 Zeroboard / skin by ROBIN